Cargando…
Impact of the COVID-19 pandemic on the course and management of chronic inflammatory immune-mediated skin diseases: What's the evidence?
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, medical professionals have been overwhelmed by questions beyond the infection itself. In dermatology practice, clinicians have been facing difficulties about the management of chronic immune-mediated skin diseases. Issues arose...
Autores principales: | Patsatsi, Aikaterini, Kyriakou, Aikaterini |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834280/ https://www.ncbi.nlm.nih.gov/pubmed/33972053 http://dx.doi.org/10.1016/j.clindermatol.2020.12.012 |
Ejemplares similares
-
A case of palisaded neutrophilic granulomatous dermatitis with subsequent development of chronic myelomonocytic leukemia
por: Kyriakou, Aikaterini, et al.
Publicado: (2019) -
Interstitial Granulomatous Dermatitis: Another Clinical Variant
por: Patsatsi, Aikaterini, et al.
Publicado: (2011) -
Linear atrophoderma of Moulin: a case report and review of the literature
por: Patsatsi, Aikaterini, et al.
Publicado: (2013) -
Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
por: Kyriakou, Aikaterini, et al.
Publicado: (2014) -
Serum Levels of TNF-α, IL-12/23p40, and IL-17 in Plaque Psoriasis and Their Correlation with Disease Severity
por: Kyriakou, Aikaterini, et al.
Publicado: (2014)